Synapse - Hans Gerdes

Results (177)

Exocrine pancreatic insufficiency induced by immune checkpoint inhibitors: A case series

Meeting Abstract

Satish, D.; Gerdes, H.; Faleck, D.
American Journal of Gastroenterology (2020)

Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies

Journal Article

Vos, E. L.; Salo-Mullen, E. E.; Tang, L. H.; Schattner, M.; Yoon, S. S.; Gerdes, H.; Markowitz, A. J.; Mandelker, D.; Janjigian, Y.; Offitt, K.; more...
JAMA Surgery (2020)

Fulltext@MSK | Save

Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis

Meeting Abstract

Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria

Meeting Abstract

Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Gastric polyps and thickened gastric folds

Book Section

Shah, P. M.; Gerdes, H.
In Chandrasekhara, V.; Elmunzer, B. J.; Khashab, M. A.; Muthusamy, V. R. (Eds.) Clinical Gastrointestinal Endoscopy. 3rd ed (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)

Meeting Abstract

Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Esophageal and Esophagogastric Junction Cancers, version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Guidelines

Ajani, J. A.; D'Amico, T. A.; Bentrem, D. J.; Chao, J.; Corvera, C.; Das, P.; Denlinger, C. S.; Enzinger, P. C.; Fanta, P.; Farjah, F.; more...
Journal of the National Comprehensive Cancer Network (2019)

Fulltext@MSK | Save

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection

Journal Article

Al Efishat, M.; Attiyeh, M. A.; Eaton, A. A.; Gönen, M.; Covey, A. M.; D'Angelica, M. I.; DeMatteo, R. P.; Kingham, T. P.; Balachandran, V.; Jarnagin, W. R.; more...
HPB (2019)

Fulltext@MSK | Save